1. Mycotic Abdominal Aortic Aneurysm after Adjuvant Therapy with Bacillus Calmette-Guérin in Patients with Urothelial Bladder Cancer: A Rare but Misinterpreted Complication
   Enrico Leo et al, 2015, Annals of Vascular Surgery CrossRef
2. A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy
   Ching-Wen Liu et al, 2016, Molecules CrossRef
3. Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M
   Qingdi Quentin Li et al, 2018, Cellular and Molecular Life Sciences CrossRef
4. Immunotherapy and Radiation – A New Combined Treatment Approach for Bladder Cancer?
   Zachary S. Buchwald et al, 2015, Bladder Cancer CrossRef
5. Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach
   QINGDI QUENTIN LI et al, 2016, International Journal of Oncology CrossRef
6. The role of LIM and SH3 protein-1 in bladder cancer metastasis
   Misaki Sato et al, 2017, Oncology Letters CrossRef
7. High-Risk Nonmuscle Invasive Bladder Cancer
   Anna Orsola et al, 2015, Hematology/Oncology Clinics of North America CrossRef
8. Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway
   Zhijun Pei et al, 2017, Oncotarget CrossRef
9. Bladder cancer selective chemotherapy with potent NQO1 substrate co-loaded prodrug nanoparticles
   Binbin Jiao et al, 2022, Journal of Controlled Release CrossRef
10. PLK-1 Silencing in Bladder Cancer by siRNA Delivered With Exosomes
    Kristin A. Greco et al, 2016, Urology CrossRef
11. Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction
    Joseph Janicki et al, 2016, Toxins CrossRef
12. Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy
    Letícia B. Silva et al, 2021, Frontiers in Bioengineering and Biotechnology CrossRef
13. Role of liposome in treatment of overactive bladder and interstitial cystitis
    Shih-Ya Hung et al, 2015, Urological Science CrossRef
14. Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics
    Qingdi Quentin Li et al, 2017, Scientific Reports CrossRef
15. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway
    Zhiyong Tuo et al, 2018, Biochemical and Biophysical Research Communications CrossRef
16. Chromatin‐regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma
    Jian‐Guo Qiu et al, 2019, Journal of Cellular Physiology CrossRef
17. Receptor-Targeting Drug and Drug Carrier for Enhanced Killing Efficacy against Non-Muscle-Invasive Bladder Cancer
    Sneha Sree Mullapudi et al, 2019, ACS Applied Bio Materials CrossRef
18. Oxymatrine inhibits proliferation of human bladder cancer T24 cells by inducing apoptosis and cell cycle arrest
    Shun Li et al, 2017, Oncology Letters CrossRef
19. Desloratadine, a Novel Antigrowth Reagent for Bladder Cancer
    Jianfeng Ma et al, 2020, Technology in Cancer Research & Treatment CrossRef
20. Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
    Boris Gershman et al, 2015, Bladder Cancer CrossRef
21. Novel anticancer therapy in BCG unresponsive non-muscle-invasive bladder cancer
    Mohamad Moussa et al, 2020, Expert Review of Anticancer Therapy CrossRef